From: Rho GTPases as therapeutic targets in Alzheimer’s disease
Treatment | Models | Effects | Reference |
---|---|---|---|
Rac1 NSC23766, 6-MP, EHT1864 | • Hippocampal neurons from 15-day-old embryonic ICR mice • HEK293, RACT17N (negative mutant), and siRNA | Decreased APP protein and mRNA levels. | [22] |
• SN4741 cells • Primary neuron cultures from the cortical lobes of E18 Sprague–Dawley rat embryos, hippocampal and entorhinal | Blocked Aβ42-associcated neuronal death. | [25] | |
• SH-SY5Y, HEK293-swAPP, and HEK293-BACE cells | Decreased Aβ protein level. Did not affect BACE, α-secretase, and Notch1. Inhibited γ-secretase, indirectly. | [52] | |
NSAIDs Ibuprofen, cicoflenac, indomethacin, fenoprofen, sulindac sulfide, meclofen, flurbiprofen | • SH-SY5Y-swAPP • PDAPP mice | Decreased Aβ42 production. | [53] |
• CHO WT-APP and PS1-M146L. • HS683-swAPP and PSN • 3-month-old Tg2576 | Decreased Aβ42 formation and increased Aβ38. Acute dosing in mice decreased Aβ42 brain levels | [54] | |
• 10-month-old Tg2576 | Reduced CNS inflammatory response and amyloid plaque pathology. | [55] | |
• Neuro2a N2a NL/N-swAPP and NotchΔE | Decreased Aβ42, no effect on Aβ40 and Notch1. | [62] | |
• H4-swAPP • CHO-sw/loAPP • 3-month-old female Tg2576 mice | Decreased Aβ42 in a γ-secretase-dependent manner both in vitro and in vivo. | [63] | |
Indomethacin | • Mild/moderate AD patients | Slight improvement in cognitive tests: Mini-Mental State Examination, Alzheimer's Disease Assessment Scale, Boston Naming Test, and Token Test. | [56] |
R-Flurbiprofen | • Mild AD patients | Ineffective at preventing/delaying loss of cognition or function. | [64] |
RhoA/ROCK Y27632, SR3677, HA-1077 | • CHO with both wild-type (WT) human APP751 and human mutant PS1. | Inhibited Aβ42 production. | [67] |
• Platelets | Inhibited cytoskeletal reorganization following activation with Aβ25–35. | [30] | |
• SH-SY5Y cells • ~2-month-old PDAPP | Lowered Aβ42 levels in vitro and in vivo. | [53] | |
• SH-SY5Y, HEK293, and primary cortical neurons from embryonic day 17 mouse embryos • 3-month-old 5 × FAD | Inhibited BACE activity and Aβ production. | [68] |